Life360 tumbles 15% after a Q2 beat. Here's why
Life360 beat on revenue and earnings but the stock sank 15%. The problem wasn't Q2, it was what management couldn't promise on growth.
.jpg)
Source: Shutterstock
Mentioned
KEY POINTS
- Q2 revenue rose 38% to US$159m and adjusted EBITDA jumped 53% to US$31.1m, both beating estimates, with advertising revenue surging 315% to a record US$22m.
- MAU growth slowed again to 16%, a second straight step down, leaving the full-year 20% target reliant on a second-half reacceleration management couldn't convincingly justify.
- FY26 revenue and EBITDA guidance was reaffirmed, but hitting the roughly 20% margin leans heavily on Q4, with Q3 guided to just 18% excluding the tariff benefit.
Everyone's trying to work out why Life360 (360) is down 15% after a second quarter that beat on revenue and earnings, with full-year guidance reaffirmed.
Below, we unpack the solid Q2 result, and an earnings call where management failed to convince analysts the company is back on track to hit its 20% MAU growth target.
2Q26 at a glance
Revenue up 38% to US$159m vs. US$156.5m ests (2% beat)
Subscription revenue up 31% to US$115.6m
Advertising revenue up 315% to a record US$22.0m
Adjusted EBITDA up 53% to US$31.1m vs. US$25.5m ests (22% beat)
Adjusted EBITDA margin of 19.6% vs. 16.3% ests (330 bp beat)
Adjusted EBITDA margins was impacted by 3% due to a one-time tariff benefit
Global MAUs up 16% to 102.4m
FY26 revenue guidance reaffirmed at US$650-685m revenue (midpoint 1% below US$671.8m ests)
FY26 adjusted EBITDA guidance reaffirmed at US$130-140m (midpoint in-line with US$135.6m ests), with a margin of approximately 20%
The earnings call
There were two key letdowns at the earnings call: Q3-4 margin guidance and MAU growth.
Life360 reaffirmed its FY26 EBITDA margin guidance of approximately 20%, but getting there leans heavily on the fourth quarter.
On the Q3 margin: "We expect Q3 adjusted EBITDA margin of approximately 18%, showing continued sequential improvement from Q2, while excluding the tariffs benefit."
On Q4 margin: "We expect Q4 2026 adjusted EBITDA margin to exceed the 22% margin we delivered in Q4 2025."
MAU growth is the metric this stock lives and dies by. At the 1Q26 result on 12 May, the shares fell 10.8% after growth came in at 17%. Q2 represents another step down at 16%, and management is asking the market to accept a second-half reacceleration that lands the full year back at 20%. Analysts pressed on what, exactly, gives them that confidence.
This is what management had to say:
"It's early on back to school, but so far we're seeing really great results, not only from the beginning of back to school, but we're actually still getting benefit from the advertising that we did in Q1. So one of the factors that is helping to drive some of the good numbers we're seeing is just an increase in brand awareness, both in the U.S. and in those newer international markets."
"Not only did we end the quarter with just really good pace, but we have got a lot of stuff in store in the back half of the year. Q3 is when we do back to school. We have a lot of exciting things in pets."
"... we got a slow start to the year. We feel really good about our pace coming out of that. We feel like we are on track to get in that range. What can I say? It is good momentum."
Where to from here?
Brand awareness, back to school, pets and "we feel like we are on track" was not enough. Markets hate uncertainty and analysts want a number they can model. What they got was more of a vibe. The stock fell as much as 18.5% to $24.00 this morning and was down 13.4% at $25.52 at the time of writing. Some deceleration is now in the price, and the rest is execution.
It's worth remembering that the stock clawed back its post-Q1 decline in under three weeks. If management can keep reaffirming that 20% target at the next couple of updates, today's selloff will look like a buying opportunity.
